X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Sequencing 101: Why Are Long Reads Important for Studying Viral Genomes?

Wednesday, April 22, 2020

The COVID-19 pandemic has brought a sudden urgency to virus research and led many of us to dig more deeply into all the tools available for characterizing viral genomes, from RT-PCR to DNA sequencing. For all their outsized impact on human health, viruses have remarkably small and simple genomes, some just a few thousand bases in length, and most lacking any repetitive structures. With such tidy genomes, you may wonder, why would scientists want to sequence them with a long-read technology like PacBio HiFi reads?

Quasispecies develop as variants are introduced to the viral genome through mutations.

While it is true that most viral genomes do not require long reads for assembly, viruses exist as populations within infected hosts, and long reads are a powerful tool for fully characterizing these populations. Depending on the mutation rate of the virus, the population structure can have one dominant variant with only a very small proportion of rare variants, or it can be comprised of a highly diverse set of closely-related variants, called a quasispecies.

Highly accurate, single-molecule sequencing allows researchers to fully characterize all the variants within a viral population, as opposed to just the dominant variant. Oftentimes this more detailed view of a complex population of viruses reveals important aspects of biology, including how a viral infection evolves over time or in response to therapeutics.

Here are some examples of how scientists have used SMRT Sequencing to explore viral genomes, and the highlights of their work.

 

Influenza: While the influenza virus continues to evade efforts to produce a universal vaccine, HiFi sequencing has given scientists a clearer picture of the dynamics of flu virus evolution. In one study, researchers sequenced multiple samples from a single patient with a two-year recurrent infection and revealed in great detail how the virus adapted in response to flu treatments. In another population-scale study tracking a flu pandemic in Hong Kong, PacBio sequencing revealed that transmission was enabled in part by minor strain variants.

In addition, scientists have used long reads to analyze large deletions in the influenza genome that characterize viruses incapable of replicating. Most recently, a study combining PacBio long reads and single-cell sequencing gave a comprehensively detailed view of how influenza mutations evolved over the course of a typical infection, revealing both point mutations and indels.

 

Hepatitis C Virus: Among the most significant challenges in HCV treatment is drug resistance. To better understand how resistance arises, scientists have deployed SMRT Sequencing to study HCV evolution in individuals who failed to respond to antiviral therapy. By using HiFi sequencing to obtain single reads encompassing entire clones, they were able to detail how multid  rug resistant variants arose from low-abundance, drug-resistant clones present at baseline.

In another example, researchers generated long-read data to produce full-length HCV envelope sequences, which allowed them to track the transmission path for a sexually transmitted cluster of HCV infections. They also reported how viral genetic diversity changed over the course of an infection, appearing low during the acute stage but increasing over time.

 

HIV: An ongoing area of research in HIV is how the virus evolves and persists in patients on long-term antiretroviral therapy (ART).  With SMRT Sequencing, scientists have generated full-length viral genome sequences from proviruses to study what proportion the latent reservoir is replication competent, and what types of mutations are favored in this reservoir under ART. A separate effort involved analyzing proviral sequences in the brain and other tissues to understand HIV-associated dementia. HiFi reads allowed the researchers to create a detailed phylogenetic tree of all the variants within an individual, and revealed that variants in the brain were distinct in important ways and absent from other parts of the body.

 

SARS-CoV-2: Recently, researchers at Mt. Sinai published a study using genetic drift in the SARS-CoV-2 virus to determine when and how the virus arrived in New York City. They found that the virus had arrived from Europe and the West Coast multiple times, though not from China, and it arrived significantly earlier than recognized. Other researchers have developed multiple long-amplicon protocols for targeted sequencing of the novel coronavirus, which may enable unique insights into the biology of SARS-CoV-2 as the pandemic, and our understanding of it, evolves.

 

To learn more about how to sequence viral genomes, explore our COVID-19 sequencing tools and resources or review our sample prep and analysis workflows for resolving viral populations.

 

Infographic: Mapping the interplay of viral and host genomics with HiFi sequencing

Learn how you can use HiFi reads to enable your viral research, from understanding viral genomes to the host immune response.

 

 

 

 


The Evolution of DNA Sequencing Tools

Introduction to PacBio Sequencing and the Sequel II System

Looking Beyond the Single Reference Genome to a Pangenome for Every Species

Understanding Accuracy in DNA Sequencing

From DNA to Discovery – The Steps of SMRT Sequencing

The Value of Sequencing Full-Length RNA Transcripts of DNA Transcripts

Subscribe for blog updates:

Archives